https://www.selleckchem.com/
To evaluate the impact of COVID-19 pandemic migitation measures on of ST-elevation myocardial infarction (STEMI) care. We previously reported a 38% decline in cardiac catheterization activations during the early phase of the COVID-19 pandemic mitigation measures. This study extends our early observations using a larger sample of STEMI programs representative of different US regions with the inclusion of more contemporary data. Data from 18 hospitals or healthcare systems in the US from January 2019 to April 2020 were collecting including number activations
Like
Comment
Share
